Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more
Ikapharmindo Putramas Tbk. (IKPM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.005x
Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) has a cash flow conversion efficiency ratio of -0.005x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-1.14 Billion) by net assets (Rp236.96 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ikapharmindo Putramas Tbk. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Ikapharmindo Putramas Tbk.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ikapharmindo Putramas Tbk. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikapharmindo Putramas Tbk. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Toppoint Holdings Inc.
NYSE MKT:TOPP
|
-0.049x |
|
MILIBOO. S.A. EO -10
F:7X2
|
N/A |
|
Glacier Media Inc
PINK:GLMFF
|
-0.056x |
|
Ravelin Properties REIT
TO:RPR-UN
|
0.020x |
|
Dave Inc. Warrants
NASDAQ:DAVEW
|
0.286x |
|
NeoTerrex Minerals Inc.
V:NTX
|
N/A |
|
Quantum Genomics SA
PA:ALQGC
|
3.110x |
|
Anew Medical, Inc.
NASDAQ:WENA
|
0.274x |
Annual Cash Flow Conversion Efficiency for Ikapharmindo Putramas Tbk. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Ikapharmindo Putramas Tbk. from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp246.12 Billion | Rp-33.68 Billion | -0.137x | -229.09% |
| 2023-12-31 | Rp244.71 Billion | Rp25.94 Billion | 0.106x | +399.21% |
| 2022-12-31 | Rp176.70 Billion | Rp3.75 Billion | 0.021x | -- |